乌干达Rakai地区病毒抑制者中复制 competent HIV-1潜伏感染细胞频率降低
该研究在乌干达Rakai地区70例慢性感染期启动ART且病毒抑制的HIV-1感染者中,用定量病毒生长试验检测潜伏感染静息CD4+ T细胞频率,中位值为0.36 IUPM,较巴尔的摩队列的1.08 IUPM低3倍(P < .001);储存库大小与调定点病毒载量正相关、与病毒抑制持续时间负相关。
要点
- 乌干达病毒抑制者潜伏储存库频率中位0.36 IUPM,较美国队列低3倍。
- 储存库大小与调定点病毒载量正相关,与病毒抑制持续时间负相关。
- 该差异机制可能对HIV-1治愈策略有参考意义。
核心结论
- 病毒抑制的乌干达感染者中,含复制 competent HIV-1的潜伏感染静息CD4+ T细胞频率较既往美国队列低3倍。
研究设计与样本
- 研究纳入乌干达Rakai地区70例慢性感染期启动ART且病毒抑制的HIV-1感染者,采集外周血。
- 采用定量病毒生长试验测定含复制 competent病毒的潜伏感染静息CD4+ T细胞频率。
- 使用多因素回归分析储存库大小的相关因素,并与既往巴尔的摩队列比较储存库大小。
主要发现
- 乌干达队列潜伏感染静息CD4+ T细胞频率中位0.36 IUPM(95%CI 0.26-0.55 IUPM)。
- 乌干达感染者储存库大小与调定点病毒载量正相关,与病毒抑制持续时间负相关。
临床怎么用
- 评估HIV储存库时需考虑人群地域差异,乌干达病毒抑制者储存库频率可能低于美国人群。
- 调定点病毒载量较高或病毒抑制持续时间较短者储存库可能更大,或需更密切监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) persists in latently infected resting CD4+ T cells (rCD4 cells), posing a major barrier to curing HIV-1 infection. Previous studies have quantified this pool of latently infected cells in Americans; however, no study has quantified this reservoir in sub-Saharan Africans, who make up the largest population of HIV-1-infected individuals globally. METHODS: Peripheral blood was collected from 70 virally suppressed HIV-1-infected individuals from Rakai District, Uganda, who had initiated antiretroviral therapy (ART) during chronic infection. The quantitative viral outgrowth assay was used to determine frequency of latently infected rCD4 cells containing replication-competent virus. Multivariate regression was used to identify correlates of reservoir size and to compare reservoir size between this Ugandan cohort and a previously studied cohort of individuals from Baltimore, Maryland. RESULTS: The median frequency of latently infected rCD4 cells in this Ugandan cohort was 0.36 infectious units per million cells (IUPM; 95% confidence interval, 0.26-0.55 IUPM), 3-fold lower than the frequency observed in the Baltimore cohort (1.08 IUPM; .72-1.49 IUPM; P < .001). Reservoir size in Ugandans was correlated positively with set-point viral load and negatively with duration of viral suppression. CONCLUSIONS: Virally suppressed Ugandans had a 3-fold lower frequency of rCD4 cells latently infected with replication-competent HIV-1, compared with previous observations in a cohort of American patients, also treated with ART during chronic infection. The biological mechanism driving the observed smaller reservoir in Ugandans is of interest and may be of significance to HIV-1 eradication efforts.
引用
- Prodger JL, Lai J, Reynolds SJ, et al. Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda. Clin Infect Dis. 2017. PMID: 28535179. doi:10.1093/cid/cix478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。